Martin Carré

1.1k citations

32 papers · 443 indexed · 1 hit paper · h-index 8

Hematology top 5%
- Acute Myeloid Leukemia Research 16
- Hematopoietic Stem Cell Transplantation 7
- Chronic Myeloid Leukemia Treatments 5
- Multiple Myeloma Research and Treatments 4
Genetics top 5%
- Blood disorders and treatments 3
Rheumatology top 10%
Oncology
- Neutropenia and Cancer Infections 3
- CAR-T cell therapy research 2
Pathology and Forensic Medicine
Molecular Biology
- Histone Deacetylase Inhibitors Research 4

Co-authors: Bruno Varet Laurence Legros Viviane Dubruille Gabriel Étienne Delphine Réa Martine Gardembas Jean‐Christophe Ianotto Michel Tulliez
Cited by: Hematology Genetics Rheumatology
Journals: Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)Blood (12 papers)
Partner nations: France Spain United States

In The Last Decade

Martin Carré

26 papers receiving 433 citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Martin Carré

Since Specialization

Citations

This map shows the geographic impact of Martin Carré's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Carré with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Carré more than expected).

Fields of papers citing papers by Martin Carré

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Carré. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Carré. The network helps show where Martin Carré may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Martin Carré, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Martin Carré Line = papers co-authored together Martin Carré links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Real-World Multicenter Comparison of Venetoclax and Azacitidine Versus Intermediate or High Dose Cytarabine-Based Salvage for Patients with AML in First Relapse after Front Line Intensive Chemotherapy. a Dataml-IPC-Auraml Consortium Study Blood ·Pierre-Yves Dumas,Sarah Bertoli,Clémence Santana,Maël Heiblig,Thibaut Leguay,Suzanne Tavitian,Éric Delabesse,Émilie Klein,Emmanuelle Tavernier,Martin Carré,Gaspar Aspas Requena,Anne Banos,Norbert Vey,Arnaud Pigneux,Christian Récher,Sylvain Garciaz	2024	0
2	Azacitidine and Venetoclax As a Salvage Therapy for Relapse after Allogeneic Transplantation for Acute Myeloid Leukemia : A Multicentric Study from French Auraml Group Blood ·Emmanuelle Tavernier,Jérôme Cornillon,Zofia Gross,Gaspar Aspas Requena,Urbain Tauveron-Jalenques,Martin Carré,Mathieu Meunier,Ugo Thévenet,Boullanger Fow Heng Nadine,Clémence Santana,Clément Rocher,Sylvain Lamure,Amine Belhabri,Mauricette Michallet,Adrien Contejean,Natacha Mauz,Gian Matteo Pica,Arthur Dony,Maël Heiblig	2024	2
3	Treatment Patterns and Clinical Outcomes of Patients with Moderate to Severe Acute Graft-Versus-Host Disease: A Multicenter Chart Review Study SHILAP Revista de lepidopterología ·David Michonneau,Raynier Devillier,Mikko Keränen,Marie Thérèse Rubio,Malin Nicklasson,Hélène Labussière‐Wallet,Martin Carré,Anne Huynh,Elisabet Viayna,Montserrat Roset,Jonathan Finzi,Minja Pfeiffer,Daniel Thunström,Núria Lara,Lorenzo Sabatelli,Patrice Chevallier,Maija Itälä‐Remes	2024	1
4	Infectious Complications Among Patients Treated with Azacitidine and Venetoclax for Acute Myeloid Leukemia: A Multicentric Real-Life Analysis of the French Auraml Group Blood ·Adrien Contejean,Pierre Chauvelot,Gaspar Aspas Requena,Urbain Tauveron-Jalenques,Martin Carré,Emmanuelle Tavernier,Jérôme Cornillon,Clémence Santana,Clément Rocher,Sylvain Lamure,Natacha Mauz,Ugo Thévenet,Boullanger Fow Heng Nadine,Gian Matteo Pica,Arthur Dony,Amine Belhabri,Mauricette Michallet,Zofia Gross,Maël Heiblig	2024	0
5	Molecular relapse after first-line intensive therapy in patients with CBF or NPM1-mutated acute myeloid leukemia – a FILO study Leukemia ·Corentin Orvain,Sarah Bertoli,Pierre Péterlin,Yohann Desbrosses,Pierre‐Yves Dumas,Alexandre Iat,Martin Carré,Emmanuelle Tavernier,Jérémie Riou,Anne Bouvier,Audrey Bidet,Sylvie Tondeur,Florian Renosi,Julien Mozziconacci,Pascale Flandrin‐Gresta,Bérengère Dadone‐Montaudié,Éric Delabesse,Arnaud Pigneux,Mathilde Hunault,Christian Récher	2024	8
6	Measurable Residual Disease (MRD) Determinants, Kinetics and Its Impact on Survival in Patients Treated with Azacitidine and Venetoclax for Acute Myeloid Leukemia in Frontline Setting : A Multicentric Study from French Auraml Group Blood ·Maël Heiblig,Gaspar Aspas Requena,Urbain Tauveron-Jalenques,Emmanuelle Tavernier,Jérôme Cornillon,Martin Carré,Mathieu Meunier,Ugo Thévenet,Boullanger Fow Heng Nadine,Clémence Santana,Clément Rocher,Sylvain Lamure,Amine Belhabri,Mauricette Michallet,Adrien Contejean,Natacha Mauz,Gian Matteo Pica,Arthur Dony,Zofia Gross	2024	0
7	Azacytidine and Venetoclax As a Salvage Therapy in Measurable Residual Disease (MRD) Relapse Post Intensive Chemotherapy or Allogenic Stem Cell Transplantation in Acute Myeloid Leukemia Patients : A Multicentric Study from French Auraml Group Blood ·Martin Carré,Mathieu Meunier,Zofia Gross,Gaspar Aspas Requena,Urbain Tauveron-Jalenques,Emmanuelle Tavernier,Jérôme Cornillon,Ugo Thévenet,Boullanger Fow Heng Nadine,Clémence Santana,Clément Rocher,Sylvain Lamure,Amine Belhabri,Mauricette Michallet,Adrien Contejean,Natacha Mauz,Gian Matteo Pica,Arthur Dony,Maël Heiblig	2024	2
8	Acute Myeloid Leukemia Patients Who Stopped Venetoclax or/and Azacytidine for Other Reasons Than Progression Have a Prolonged Treatment Free Remission and Overall Survival. a Filo Study Blood ·Sylvain Garciaz,Sarah Bertoli,David A. Sallman,Justine Decroocq,Pierre‐Yves Dumas,Amine Belhabri,Corentin Orvain,Gaspar Aspas Requena,Célestine Simand,Kamel Laribi,Martin Carré,Alberto Santagostino,Ludovic Gabellier,Ariane Mineur,Arnaud Pigneux,Norbert Vey,Christian Récher	2023	7
9	Chronic Myelomonocytic Leukemia Patients With Lysozyme Nephropathy and Renal Infiltration Display Markers of Severe Disease Kidney International Reports ·(unknown),(unknown),Helmut G. Rennke,Marie Essig,Martin Carré,Lucile Mercadal,Jonathan Farhi,Hamza Sakhi,Thibault Comont,Léonard Golbin,Pierre Isnard,Jonathan Chemouny,(unknown),Kamel Laribi,Umut Selamet,Leonardo V. Riella,(unknown),(unknown),(unknown),Camille Cohen,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Pierre Fenaux,(unknown),(unknown),Nathalie Cambier,(unknown),(unknown),(unknown),(unknown),A. Mékinian,(unknown),Lionel Adès,(unknown)	2023	2
10	Molecular Relapse after First-Line Intensive Therapy in Patients with Core-Binding Factor and NPM1-Mutated Acute Myeloid Leukemia - a Filo Study Blood ·Corentin Orvain,Sarah Bertoli,Pierre Péterlin,Yohan Desbrosses,Pierre‐Yves Dumas,Alexandre Iat,Martin Carré,Emmanuelle Tavernier,Anne Bouvier,Audrey Bidet,Sylvie Tondeur,Florian Renosi,Éric Delabesse,Arnaud Pigneux,Hunault-Berger Mathilde,Christian Récher	2023	0
11	Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AML Scientific Reports ·Emmanuel Gyan,Arnaud Pigneux,Mathilde Hunault,Pierre Péterlin,Martin Carré,Jacques‐Olivier Bay,Caroline Bonmati,Maria-Pilar Gallego-Hernanz,Bruno Lioure,Philìppe Bertrand,Nicolas Vallet,David Ternant,François Darrouzain,Frédéric Picou,Marie C. Béné,Christian Récher,Olivier Hérault	2022	2
12	Long-Term Survival of Acute Myeloid Leukemia Responding Patients Who Stopped Azacytidine and/or Venetoclax Because of Poor Tolerance or Physician Choice: A Retrospective Multicenter Study from the French Innovative Leukemia Organization (FILO) Blood ·Sylvain Garciaz,Justine Decroocq,Sarah Bertoli,Amine Belhabri,Pierre‐Yves Dumas,Célestine Simand,Kamel Laribi,Alberto Santagostino,Martin Carré,Aline Schmidt,Gaspard Aspas Requena,Chantal Himberlin,Christian Récher,Norbert Vey	2022	2
13	Total body irradiation using helical tomotherapy: Set-up experience and in-vivo dosimetric evaluation Cancer/Radiothérapie ·Julie Cleuziou,Charline Desgranges,I. Henry,M. Jaumot,P. Chartier,R. Sihanath,Martin Carré,Claude‐Eric Bulabois,J Cahn,C. Pasteris,Jacques Balosso,Isabelle Gabelle-Flandin,Camille Verry,Jean-Yves Giraud	2021	9
14	Neutropenia in patients treated with clozapine during COVID-19 infection European Psychiatry ·J. Martí Bonany,Martin Carré,J.R. Fortuny Olive,C. Macias Castellví,Eduardo Diez,Roberto Sánchez,M. Vallvé Elias,G. Mateu-Codina,Montserrat Casamitjana	2021	0
15	Diversification alimentaire chez les enfants de 6 à 12 mois : connaissances des parents et facteurs influençant leurs pratiques Journal de Pédiatrie et de Puériculture ·Michaël Rochoy,A. Mameche-Yazit,T. Puszkarek,Martin Carré	2021	1
16	Agranulocytoses médicamenteuses idiosyncrasiques : analyse de 7 ans dans un hôpital universitaire français Annales Pharmaceutiques Françaises ·Marie Duwez,Gautier Szymanski,Martin Carré,Michel Mallaret,Marion Lepelley	2020	1
17	Maternal adherence to guidance on breast milk collection process Archives de Pédiatrie ·Martin Carré,Delphine Dumoulin,R. Jounwaz,Béatrice Mestdagh,Véronique Pierrat	2018	11
18	Fatal autochthonous fulminant hepatitis E early after allogeneic stem cell transplantation Bone Marrow Transplantation ·Martin Carré,Anne Thiebaut‐Bertrand,Sylvie Larrat,Vincent Leroy,P Pouzol,Nathalie Stürm,Sébastien Lhomme,J Cahn,Frédéric Garban,Patrice Morand	2017	8
19	Alemtuzumab for Severe Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease Biology of Blood and Marrow Transplantation ·Mathieu Meunier,Claude‐Eric Bulabois,Anne Thiebaut‐Bertrand,Raphaël Itzykson,Martin Carré,Sylvain Carras,Frédéric Garban,J Cahn	2014	13
20	[Possible embryofetopathy caused by beta-blocker (sotalol) taken throughout the pregnancy]. PubMed ·J P Babin,Martin Carré,C Martín	1985	7

About Martin Carré

Martin Carré is a scholar working on Hematology, Genetics and Oncology, having authored 32 papers that have together received 443 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (16 papers), Hematopoietic Stem Cell Transplantation (7 papers), Chronic Myeloid Leukemia Treatments (5 papers), Multiple Myeloma Research and Treatments (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Blood disorders and treatments (3 papers), Neutropenia and Cancer Infections (3 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Hematology (341 citations), Genetics (249 citations) and Rheumatology (130 citations). Martin Carré has collaborated with scholars based in France, Spain and United States. Frequent co-authors include Bruno Varet, Laurence Legros, Viviane Dubruille, Gabriel Étienne, Delphine Réa, Martine Gardembas, Jean‐Christophe Ianotto, Michel Tulliez, Franck E. Nicolini and Aude Charbonnier. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact